CHEMED CORP
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
CHE$544.49+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| CONSOLIDATED STATEMENTS OF CHANGES | ||||||
|---|---|---|---|---|---|---|
| IN STOCKHOLDERS' EQUITY | ||||||
| Chemed Corporation and Subsidiary Companies | ||||||
| (in thousands, except per share data) · Deferred | ||||||
| Compensation | ||||||
| Treasury · Payable in | ||||||
| Capital · Paid-in · Retained · Stock- · Company | ||||||
| Stock | Capital | Earnings | at Cost | Stock | Total | |
| Balance at December 31, 2022 | $36,796 | $1,149,899 | $2,197,918 | $(2,588,145) | $2,247 | $798,715 |
| Net income | - | - | 272,509 | - | - | 272,509 |
| Dividends paid ($1.56 per share) | - | - | (23,502) | - | - | (23,502) |
| Stock awards and exercise of stock options (Note 4) | 388 | 190,835 | - | (57,796) | - | 133,427 |
| Purchases of treasury stock (Note 19) | - | - | - | (73,813) | - | (73,813) |
| Other | - | 539 | - | 166 | (165) | 540 |
| Balance at December 31, 2023 | $37,184 | $1,341,273 | $2,446,925 | $(2,719,588) | $2,082 | $1,107,876 |
| Net income | - | - | 301,999 | - | - | 301,999 |
| Dividends paid ($1.80 per share) | - | - | (27,092) | - | - | (27,092) |
| Stock awards and exercise of stock options (Note 4) | 238 | 144,878 | - | (45,947) | - | 99,169 |
| Purchases of treasury stock (Note 19) | - | - | - | (358,737) | - | (358,737) |
| Excise tax on share repurchase | - | - | - | (2,246) | - | (2,246) |
| Other | - | (1,975) | - | (142) | 141 | (1,976) |
| Balance at December 31, 2024 | $37,422 | $1,484,176 | $2,721,832 | $(3,126,660) | $2,223 | $1,118,993 |
| Net income | - | - | 265,238 | - | - | 265,238 |
| Dividends paid ($2.20 per share) | - | - | (31,695) | - | - | (31,695) |
| Stock awards and exercise of stock options (Note 4) | 173 | 106,850 | - | (50,010) | - | 57,013 |
| Purchases of treasury stock (Note 19) | - | - | - | (428,035) | - | (428,035) |
| Excise tax on share repurchase | - | - | - | (3,282) | - | (3,282) |
| Other | - | 1,171 | - | (130) | 132 | 1,173 |
| Balance at December 31, 2025 | $37,595 | $1,592,197 | $2,955,375 | $(3,608,117) | $2,355 | $979,405 |
| The Notes to Consolidated Financial Statements are integral parts of these statements. | ||||||
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.